Serenoa Repens Prostata

Palmier pitic, Serenoa Repens, Sabal Serulata

1 Serenoa Repens un fito farmaceutic indicat la hiperplazia benigna de prostata, studiu randomizat, dublu-orb, placebo controlat.

2 Serenoa Repens update meta analiza in tratamentul simptomatic la hiperplazia benigna de prostata.

Serenoa Repens Prostata

Palmier pitic, Serenoa Repens, Sabal Serulata

Palmier pitic - Serenoa Repens, Saw Palmetto (Sabal Serulata) foto

1 Serenoa Repens (Sabal Serulata), Palmier pitic - Serenoa Repens un fito farmaceutic indicat la hiperplazia benigna de prostata, studiu randomizat, dublu-orb, placebo controlat.

2 Serenoa Repens (Sabal Serulata), Palmier pitic - Serenoa Repens update meta analiza in tratamentul simptomatic la hiperplazia benigna de prostata.

3 Serenoa Repens (Sabal Serulata) o planta naturala in hiperplazia benigna de prostata, studiu randomizat, dublu-orb, placebo controlat.

Saw Palmetto produse-naturale fata de Proscar (finasteride) si de trei ori mai ieftin - 300%

4 Fructul de Serenoa Repens (Sabal Serulata) ca: Supliment nutritiv

Palmier pitic (Sabal Serulata) Fructul de Serenoa Repens ca: Supliment nutritiv

5 Fitoterapia cu Pygeum Africanum, Serenoa Repens si Urzica (Urtica Dioica) in hiperplazia beningna de prostata

6 Reviu critic si farmacologic la Pygeum Africanum in tratamentul simptomelor caracteristice de urinari dese

7 Fitoterapia cu Pygeum si Serenoa Repens la hiperplazia beningna de prostata, evaluarea curenta a evidentelor bazate

8. Reviu recent: Agenti Fitoterapeutici in hiperplazia beningna de prostata, studiu randomizat, dublu-orb, placebo controlat.

9 Serenoa Repens (Sabal Serulata) in menagementul simptomelor cu hiperplazie beningna de prostata

10 Fructul de Serenoa Repens (Sabal Serulata) in studiul de tratament la 1334 pacienti cu hiperplazie beningna de prostata

11 Serenoa Repens (Sabal Serulata) indicat in terapia adenomului de prostata, studiu randomizat, dublu-orb, placebo controlat.

12 Serenoa Repens (Sabal Serulata) in tratamentul adenomului de prostata si prostatita cronica bacteriana

13 Serenoa Repens (Sabal Serulata) indicat in hiperplazia beningna de prostata

14. Serenoa Repens (Sabal Serulata) inhiba 5-Alfa reductaza care interfereaza conversia testosteronului in dihidrotestosteron (DHT)

- Conversia de androgeni in estrogeni se numeste aromataza.

15 Serenoa Repens (Sabal Serulata): Noul principiu cu actiune antiflogistica

16 Serenoa Repens (Sabal Serulata) cu activitate evidenta anti estrogenica in tesutul de prostata la hiperplazia beningna de prostata

17 Serenoa Repens (Sabal Serulata) un liposterol inhiba receptorii de androgeni in cultura de fibroblast

18 Serenoa Repens (Sabal Serulata) contine fitosteroli cu actiune de libido la hiperplazia beningna de prostata

19 Serenoa Repens (Sabal Serulata) in tratamentul simptomelor caracteristice de urinari dese - incontinenta urinara

20 Palmierul pitic numit Serenoa Repens (Sabal Serulata) in tratamentul barbatilor cu simptomele caracteristice de urinari dese

21 Serenoa Repens (Sabal Serulata) in tratamentul barbatilor cu simptomele caracteristice de urinari dese, studiu randomizat, dublu-orb, placebo controlat.

22 Serenoa Repens (Sabal Serulata) in tratamentul simtomatic obstructiv cauzat de adenomul prostatic, studiu randomizat, dublu-orb, placebo controlat.

23 Serenoa Repens (Sabal Serulata) un fitosterol cu actiune de libido in managementul simptomele caracteristice in urinari dese asociat cu hiperplazia beningna de prostata

24. Serenoa Repens si Urzica (Urticae radix) radacina un viabil tratament medical la hiperplazia beningna de prostata asociat cu simptomele caracteristice in urinari dese, eficacitate excelenta pentru Serenoa, pentru Urzica, in mai mult de 80% cazuri, spune departamentul farmacologic

30 Serenoa Repens (Sabal Serulata) si Urzica pentru barbati la Alopecie - caderea parului (alopecia areata)

- O boala autoimmuna la care este afectat sistemul imunitar (celulele albe)

Limfocitele -T ataca foliculele de par

- Controlul functiei celulelor T de neurotrofine (polipeptide), in pielea afectata de alopecie - caderea parului (alopecia areata)

Factorul de crestere nervoasa (NGF) un polipeptid din familia de neurotrofine

Alopecie totala (alopecia totalis)

Alopecie universala (alopecia universalis)

31 Serenoa Repens (Sabal Serulata) mai eficace si mai ieftin ca finasteride de trei ori

32 Serenoa Repens (Sabal Serulata): Reviu farmacologic si terapeutic eficace in hiperplazia beningna de prostata

33. Indole-3-Carbinol, Diindolylmethane si sulforafan cu efect la cancerul de prostata: dihidrotestosteronul (DHT) blocker

Indole-3-Carbinol, si Diindolylmethane si sulforafan cu efect la cancerul de prostata: dihidrotestosteronul (DHT) blocker

34. Diindolylmethane la adenomul de prostata (hiperplazia benigna de prostata) si cancer

35. Nivelul seric plasmatic ridicat de estron la barbati obezi

36. Nivelul seric de estradiol la barbati cu infarct miocardic acut

Nivelul seric de estradiol la barbati cu infarct miocardic acut

37. Asociatia de hiperestrogenemia cu cardiopatia ischemica cronica la barbati

38. Evidenta de hiperestrogenemia un factor de risc in infarctul miocardic la barbati

Echilibru hormonal pentru barbati si femei: Diindolylmethane si Indole-3-Carbinol

Bibliografie-Referinte: Serenoa Repens

Informatii din bibliografia electronica la tema: Nutritie si sanatate

1 Gerber GS. Phytotherapy for benign prostatic hyperplasia. Section of Urology, University of Chicago, 5841 S. Maryland Avenue, MC 6038, Chicago, IL 60637, USA. Curr Urol Rep. 2002 Aug;3(4):285-91.
- Willetts KE, Clements MS, Champion S, Ehsman S, Eden JA. Serenoa repens extract for benign prostate hyperplasia: a randomized controlled trial. Natural Therapies Unit, Royal Hospital for Women, Randwick, Australia. BJU Int. 2003 Aug;92(3):267-70.
2 Boyle P, Robertson C, Lowe F, Roehrborn C. Updated meta-analysis of clinical trials of Serenoa repens extract in the treatment of symptomatic benign prostatic hyperplasia. Department of Epidemiology and Biostatistics, European Institute of Oncology, via Ripamonti 435, 20141 Milan, Italy. BJU Int. 2004 Apr;93(6):751-6.
3 Champault G, Patel JC, Bonnard AM. A double-blind trial of an extract of the plant Serenoa repens in benign prostatic hyperplasia. Br J Clin Pharmacol. 1984 Sep;18(3):461-2
4 FEURT SD, FOX LE. A note on the effects of feeding saw palmetto berries, Serenoa repens (Bartram) Small, to rats. J Am Pharm Assoc Am Pharm Assoc (Baltim). 1954 Oct;43(10):636-8.
5 Wilt TJ, Ishani A, Rutks I, MacDonald R. Phytotherapy for benign prostatic hyperplasia.Minneapolis VA Center for Chronic Diseases Outcomes Research, MN 55417, USA. Public Health Nutr. 2000 Dec;3(4A):459-72.
6 Edgar AD, Levin R, Constantinou CE, Denis L. A critical review of the pharmacology of the plant extract of Pygeum africanum in the treatment of LUTS. Fournier Pharma, Daix, France. Neurourol Urodyn. 2007;26(4):458-63
- Fong YK, Milani S, Djavan B. Role of phytotherapy in men with lower urinary tract symptoms. Department of Urology, University of Vienna, Vienna, Austria. Curr Opin Urol. 2005 Jan;15(1):45-8.
7 Dreikorn K, Berges R, Pientka L, Jonas U. Phytotherapy of benign prostatic hyperplasia. Current evidence-based evaluation Urologische Klinik, Zentralkrankenhaus, St.-Jürgen-Str., 28205 Bremen. Urologe A. 2002 Sep;41(5):447-51
8. Lowe FC, Dreikorn K, Borkowski A, Braeckman J, Denis L, Ferrari P, Gerber G, Levin R, Perrin P, Senge T. Review of recent placebo-controlled trials utilizing phytotherapeutic agents for treatment of BPH. Department of Urology, St. Luke's-Roosevelt Hospital, New York, New York 10019, USA. Prostate. 1998 Nov 1;37(3):187-93
9 Kondás J, Philipp V, Diószeghy G. Sabal serrulata extract in the management of symptoms of prostatic hypertrophy Fóvárosi Onkormányzat Péterfy Sándor utcai Kórház-Rendelóintézet, Urológiai-sebészeti Osztály, Budapest. Orv Hetil. 1997 Feb 16;138(7):419-21
10 Vahlensieck W Jr, Völp A, Lubos W, Kuntze M. Benign prostatic hyperplasia--treatment with sabal fruit extract. A treatment study of 1,334 patients Urologische Klinik und Poliklinik, Klinikum Grosshadern der Universität München. Fortschr Med. 1993 Jun 30;111(18):323-6.
11 Tasca A, Barulli M, Cavazzana A, Zattoni F, Artibani W, Pagano F. Treatment of obstructive symptomatology caused by prostatic adenoma with an extract of Serenoa repens. Double-blind clinical study vs. placebo Minerva Urol Nefrol. 1985 Jan-Mar;37(1):87-91.
12 Aliaev IuG, Vinarov AZ, Lokshin KL, Spivak LG. Extracts Serenoa repens in the treatment of prostatic adenoma and chronic abacterial prostatitis: results of short-term (3-month courses) therapy Urologiia. 2007 Mar-Apr;(2):80-2.
13 Wilt T, Ishani A, Stark G, MacDonald R, Mulrow C, Lau J. Serenoa repens for benign prostatic hyperplasia. General Internal Medicine (111-0), Minneapolis VA/VISN 13 Center for Chronic Diseases Outcomes Research, One Veterans Drive, Minneapolis, Minnesota 55417, USA. Cochrane Database Syst Rev. 2000;(2):CD001423.
- Wilt T, Ishani A, Mac Donald R. Serenoa repens for benign prostatic hyperplasia. General Internal Medicine (111-0), Minneapolis VA/VISN 13 Center for Chronic Disease Outcomes Research, One Veterans Drive, Minneapolis, Minnesota 55417, USA. Cochrane Database Syst Rev. 2002;(3):CD001423.
- Gordon AE, Shaughnessy AF. Saw palmetto for prostate disorders. Harrisburg Family Practice Residency Harrisburg, Pennsylvania 17110-2098, USA. agordon@pinnacle.health.org Am Fam Physician. 2003 Mar 15;67(6):1281-3.
- Wilt TJ, Ishani A, Stark G, MacDonald R, Lau J, Mulrow C. Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review. Department of Veterans Affairs Coordinating Center of the Cochrane Collaborative Review Group in Prostatic Diseases and Urologic Malignancies, Minneapolis Veterans Affairs Medical Center, Minn 55417, USA. JAMA. 1998 Nov 11;280(18):1604-9.
- McPartland JM, Pruitt PL. Benign prostatic hyperplasia treated with saw palmetto: a literature search and an experimental case study. Department of Family Practice, University of Vermont, USA. J Am Osteopath Assoc. 2000 Feb;100(2):89-96.
- Marks LS, Partin AW, Epstein JI, Tyler VE, Simon I, Macairan ML, Chan TL, Dorey FJ, Garris JB, Veltri RW, Santos PB, Stonebrook KA, deKernion JB. Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia.Department of Urology, University of California Los Angeles School of Medicine, Los Angeles, CA, USA. J Urol. 2000 May;163(5):1451-6.
- Preuss HG, Marcusen C, Regan J, Klimberg IW, Welebir TA, Jones WA. Randomized trial of a combination of natural products (cernitin, saw palmetto, B-sitosterol, vitamin E) on symptoms of benign prostatic hyperplasia (BPH). Department of Physiology and Biophysics, Georgetown University Medical Center, Washington, DC 20007, USA.Int Urol Nephrol. 2001;33(2):217-25.
14. Weisser H, Tunn S, Behnke B, Krieg M. Effects of the sabal serrulata extract IDS 89 and its subfractions on 5 alpha-reductase activity in human benign prostatic hyperplasia. Institute of Clinical Chemistry, Transfusion and Laboratory Medicine, University Clinic Bergmannsheil, Bochum, Federal Republic of Germany. Prostate. 1996 May;28(5):300-6.Links
15 Wagner H, Flachsbarth H, Vogel G. A New Antiphlogistic Principle from Sabal serrulata, II. Institut für pharmazeutische Arzneimittellehre der Universität München. Planta Med. 1981 Mar;41(3):252-8.
16 Di Silverio F, D'Eramo G, Lubrano C, Flammia GP, Sciarra A, Palma E, Caponera M, Sciarra F. Evidence that Serenoa repens extract displays an antiestrogenic activity in prostatic tissue of benign prostatic hypertrophy patients.Department of Urology U. Bracci, University of Rome La Sapienza, Italy. Eur Urol. 1992;21(4):309-14.
17 Sultan C, Terraza A, Devillier C, Carilla E, Briley M, Loire C, Descomps B. Inhibition of androgen metabolism and binding by a liposterolic extract of "Serenoa repens B" in human foreskin fibroblasts. J Steroid Biochem. 1984 Jan;20(1):515-9.
18 Giannakopoulos X, Baltogiannis D, Giannakis D, Tasos A, Sofikitis N, Charalabopoulos K, Evangelou A. The lipidosterolic extract of Serenoa repens in the treatment of benign prostatic hyperplasia: a comparison of two dosage regimens. Department of Urology, Ioannina University School of Medicine, Ioannina, Greece. Adv Ther. 2002 Nov-Dec;19(6):285-96.
19 Gerber GS, Zagaja GP, Bales GT, Chodak GW, Contreras BA. Saw palmetto (Serenoa repens) in men with lower urinary tract symptoms: effects on urodynamic parameters and voiding symptoms. Department of Surgery, University of Chicago Pritzker School of Medicine, Illinois, USA. Urology. 1998 Jun;51(6):1003-7.
20 Gerber GS. Saw palmetto for the treatment of men with lower urinary tract symptoms. Section of Urology, Department of Surgery, University of Chicago Pritzker School of Medicine, Chicago, Illinois, USA. J Urol. 2000 May;163(5):1408-12
21 Gerber GS, Kuznetsov D, Johnson BC, Burstein JD. Randomized, double-blind, placebo-controlled trial of saw palmetto in men with lower urinary tract symptoms. Section of Urology, Department of Surgery, University of Chicago Pritzker School of Medicine, Chicago, Illinois, USA Urology. 2001 Dec;58(6):960-4; discussion 964-5.
22 Tasca A, Barulli M, Cavazzana A, Zattoni F, Artibani W, Pagano F. Treatment of obstructive symptomatology caused by prostatic adenoma with an extract of Serenoa repens. Double-blind clinical study vs. placebo Minerva Urol Nefrol. 1985 Jan-Mar;37(1):87-91.
23 Gerber GS, Fitzpatrick JM. The role of a lipido-sterolic extract of Serenoa repens in the management of lower urinary tract symptoms associated with benign prostatic hyperplasia. Division of Urology, University of Chicago Medical School, Chicago, IL 60637, USA. BJU Int. 2004 Aug;94(3):338-44.
24. Koch E. Extracts from fruits of saw palmetto (Sabal serrulata) and roots of stinging nettle (Urtica dioica): viable alternatives in the medical treatment of benign prostatic hyperplasia and associated lower urinary tracts symptoms. Department of Pharmacology, Dr. Willmar Schwabe Arzneimittel GmbH, Karlsruhe, Germany. Planta Med. 2001 Aug;67(6):489-500.
25. Kaufman, K. D. Androgens and alopecia. Mol. Cell Endocrinol. 2002; 198(1-2): 89-95
- Chizick, S., et al. Natural preparation for treatment of male pattern hair loss. U.S. Patent #5,972,345. 1999.
26. Krieg M, Nass R, Tunn S. Effect of aging on endogenous level of 5 alpha-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate. Institute of Clinical Chemistry and Laboratory Medicine, University Clinic Bergmannsheil, Bochum, Germany. J Clin Endocrinol Metab. 1993 Aug;77(2):375-81.
27. Dvorkin L, Song KY. Herbs for benign prostatic hyperplasia. Center for Integrative Therapies in Pharmaceutical Care, Massachusetts College of Pharmacy and Health Sciences, Boston, MA 02115-5896, USA. Ann Pharmacother. 2002 Sep;36(9):1443-52.
28. Farnsworth WE, Roles of estrogen and SHBG in prostate physiology. The Prostate 1996; 28:17-23.
29. Nakhla AM, Romas NA, Rosner W. Estradiol activates the prostate androgen receptor and prostate-specific antigen secretion through the intermediacy of sex hormone-binding globulin. Department of Medicine, St. Luke's/Roosevelt Hospital Center, New York, New York 10019 and the College of Physicians and Surgeons, Columbia University, New York, New York 10019, USA. J Biol Chem. 1997 Mar 14;272(11):6838-41.
30 Dean K. Saw palmetto (Serenoa repens), and nettles, for male pattern baldness. HerbalGram. 2000;49:31.
31 Sökeland J, Albrecht J. Combination of Sabal and Urtica extract vs. finasteride in benign prostatic hyperplasia (Aiken stages I to II. Comparison of therapeutic effectiveness in a one year double-blind study Urologische Klinik Dortmund, Lehrkrankenhaus der Universitat Münster. Urologe A. 1997 Jul;36(4):327-33.
- Sökeland J. Combined sabal and urtica extract compared with finasteride in men with benign prostatic hyperplasia: analysis of prostate volume and therapeutic outcome. Urological Clinic of Dortmund, Training Hospital of the University of Münster, Germany. BJU Int. 2000 Sep;86(4):439-42.
- Gordon AE, Shaughnessy AF. Saw palmetto for prostate disorders. Harrisburg Family Practice Residency Harrisburg, Pennsylvania 17110-2098, USA. agordon@pinnacle.health.org Am Fam Physician. 2003 Mar 15;67(6):1281-3.
32 Plosker GL, Brogden RN. Serenoa repens (Permixon). A review of its pharmacology and therapeutic efficacy in benign prostatic hyperplasia. Adis International Limited, Auckland, New Zealand. Drugs Aging. 1996 Nov;9(5):379-95.
33. Frydoonfar HR, McGrath DR, Spigelman AD. The effect of indole-3-carbinol and sulforaphane on a prostate cancer cell line. Discipline of Surgical Science, Faculty of Health, The University of Newcastle, New South Wales, Australia. ANZ J Surg. 2003 Mar;73(3):154-6.
34. Zeligs MA, Sepkovic DW, Manrique CA, Macksalka M, Williams DE, Bradlow HL, "Absorption-enhanced 3,3-Diindolylmethane: human use in HPV-related, benign and pre-cancerous conditions." American Association of Cancer Research, (42) 2002, #103483.
35. Brind J, Strain G, Miller L, Zumoff B, Vogelman J, Orentreich N. Obese men have elevated plasma levels of estrone sulfate. Orentreich Foundation for the Advancement of Science Inc., Biomedical Research Station, Cold Spring-on-Hudson, NY 10516. Int J Obes. 1990 Jun;14(6):483-6.
36. Klaiber EL, Broverman DM, Haffajee CI, Hochman JS, Sacks GM, Dalen JE. Serum estrogen levels in men with acute myocardial infarction. Am J Med. 1982 Dec;73(6):872-81.
37. Phillips GB, Castelli WP, Abbott RD, McNamara PM. Association of hyperestrogenemia and coronary heart disease in men in the Framingham cohort. Am J Med. 1983 May;74(5):863-9.
38. Philips GB, Evidence for hyperoestrogenaemia as a risk factor for myocardial infarction in men. Lancet 1976; 2(7975): 14-18.

Parerea din pasajele acestui site nu a fost independent cercetate sau confirmate.